Quick, simple nasal swab helps diagnose type of asthma in children
A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...
Screening for physical inactivity can cut risk of chronic illness, study suggests
Encouraging primary care physicians to screen patients for physical inactivity with a simple questionnaire can help identify ...
WISH-TV on MSN4h
Lilly’s Zepbound approved by FDA for sleep apnea treatment
The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...
pharmaphorum22h
Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller
Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.
The New York Times1d
New York Times - Top Stories
Driver Rams Pickup Into Crowd in New Orleans, Killing 10 LIVE Attacker’s Truck Had Islamic State Flag, F.B.I. Says Officials said they did not believe the suspect, who died after a shootout with ...